Antimicrobial susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in two successive respiratory seasons in the US

International Journal of Antimicrobial Agents

Volumn 20, Issue 2, 2002, Pages 76-85

  Karlowsky, James A ^a   Draghi, Deborah C ^a   Thornsberry, Clyde ^b   Jones, Mark E ^c   Critchley, Ian A ^a   Sahm, Daniel F ^a  

^a Focus Technologies Incorporated   (United States)

^b Focus Technologies   (United States)

^c Focus Technologies   (Netherlands)

Author keywords

Antimicrobial susceptibility testing; Haemophilus influenzae; Moraxella catarrhalis; Streptococcus pneumoniae

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; AZITHROMYCIN; BETA LACTAMASE; CEFDITOREN; CEFPROZIL; CEFTRIAXONE; CEFUROXIME; COTRIMOXAZOLE; LEVOFLOXACIN; PENICILLIN G;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; CONTROLLED STUDY; HAEMOPHILUS INFLUENZAE; MORAXELLA CATARRHALIS; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE; UNITED STATES;

ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; DRUG RESISTANCE, BACTERIAL; HAEMOPHILUS INFLUENZAE; HUMANS; MICROBIAL SENSITIVITY TESTS; MORAXELLA (BRANHAMELLA) CATARRHALIS; RESPIRATORY TRACT INFECTIONS; STREPTOCOCCUS PNEUMONIAE; UNITED STATES;

EID: 0036701554     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(02)00124-3     Document Type: Article

References (13)

1. Doern G.V., Heilmann K.P., Huynh H.K., Rhomberg P.R., Coffman S.L., Brueggeman A.B. Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000, including a comparison of resistance rates since 1994-1995. Antimicrob. Agents Chemother. 45:2001;1721-1729.
2. Sahm D.F., Karlowsky J.A., Kelly L.J., et al. Need for annual surveillance of antibiotic resistance in Streptococcus pneumoniae in the United States: 2-year longitudinal analysis. Antimicrob. Agents Chemother. 45:2001;1037-1042.
3. Hoban D.J., Doern G.V., Fluit A.C., Roussel-Delvallez M., Jones R.N. Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY antimicrobial surveillance program, 1997-1999. Clin. Infect. Dis. 32:(Suppl 2):2001;S81-S93.
4. Thornsberry C., Oglivie P., Kahn J., Mauriz Y. The Laboratory Investigator Group. Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in the 1996-1997 respiratory season. Diagn. Microbiol. Infect. Dis. 29:1997;249-257.
5. Butler J.C., Hofmann J., Cetron M.S., Elliott J.A., Facklam R.R., Breiman R.F. The pneumococcal sentinel surveillance working group. The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: an update from the centers for disease control and prevention's pneumococcal sentinel surveillance system. J. Infect. Dis. 174:1996;986-993.
6. Karlowsky J.A., Draghi D.C., Critchley I.A., et al. Impact of patient age and geographic location, antimicrobial susceptibility: data on outpatient respiratory isolates. J. Resp. Dis. 22:(Suppl 8):2001;S32-S42.
7. Centers for Disease Control and Prevention. Geographic variation in penicillin resistance in Streptococcus pneumoniae-selected sites, United States, 1997. MMWR Morb Mortal Wkly Report 1999;48:656-61.
8. Thornsberry C., Jones M.E., Hickey M.L., Mauriz Y., Kahn J., Sahm D.F. Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in the United States, 1997-1998. J. Antimicrob. Chemother. 44:1999;749-759.
9. Baquero F., Garcia-Rodriguez J.A., Garcia de Lomas J., Aguilar L. The Spanish Surveillance Group for Respiratory Pathogens. Antimicrobial resistance of 1,113 Streptococcus pneumoniae isolates from patients with respiratory tract infections in Spain: results of a 1-year (1996-1997) multicenter surveillance study. Antimicrob. Agents Chemother. 43:1999;357-359.
10. Whitney C.G., Farley M.M., Hadler J., et al. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. New Engl. J. Med. 343:2000;1917-1924.
11. Jones R.N., Biedenbach D.J., Croco M.A.T., Barrett M.S. In vitro evaluation of a novel orally administered cephalosporin (cefditoren) tested against 1249 recent clinical isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae. Diagn. Microbiol. Infect. Dis. 31:1998;573-578.
12. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically; Approved Standard, Fifth Edition, vol. 20, No. 2. M7-A5. National Committee for Clinical Laboratory Standards, Wayne, PA, 2000.
13. National Committee on Clinical Laboratory Standards. Performance standard for antimicrobial susceptibility testing; tenth informational supplement, M100-S10, Vol. 20, No.1. National Committee for Clinical Laboratory Standards, Wayne, PA, 2000.